Clinical trial
Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity
NCT00477048 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed
Key facts
| NCT number | NCT00477048 |
|---|---|
| Title | Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity |
| Official title | Efficacy and Safety of a Saquinavir Based Regimen in HIV-1 Infected Thai Patients Who Have Chronic IDV Associated Nephrotoxicity. |
| Lead sponsor | The HIV Netherlands Australia Thailand Research Collaboration, Other |
| Collaborators | Roche Pharma AG Industry Ministry of Health, Thailand |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | IDV Associated Nephrotoxicity |
| Intervention type | Drug |
| Interventions | Saquinavir |
| Enrollment | 30 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 22, 2007 |
| Last update posted | Feb 22, 2016 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: